Abstract
Ranpirnase (ONC) induced a significant increase in blood flow and oxygen saturation, along with significant growth inhibition in NSCLC. ONC may be a promising drug for the treatment of NSCLC patients.
© 2006 Optical Society of America
PDF ArticleMore Like This
U. Sunar, S. Makonnent, H. W. Wang, T. Durduran, C. Zhou, G. Yu, W. M. F. Leet, and A. G. Yodh
TuC2 Biomedical Topical Meeting (BIOMED) 2006
Ulaş Sunar, H. Quon, J. Zhang, J. Du, T. Durduran, C. Zhou, G. Yu, A. Kilger, R. Lustig, L. Loevner, S. Nioka, B. Chance, and A. G. Yodh
MI7 Biomedical Topical Meeting (BIOMED) 2006
Guoqiang Yu, Turgut Durduran, Chao Zhou, Gwen Lech, Emile R. Mohler, and Arjun G. Yodh
ME44 Biomedical Topical Meeting (BIOMED) 2006